Delivery Order SPE2DB20D3101-SPE2DB23FRKN3
Award Date 5/3/23
Potential Completion Date 5/4/23
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,846.76 firm fixed-price delivery order is for the supply of 4,557,876,692 capsules of the drug cevimeline hydrochloride, a medication used to treat dry mouth. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,344.44 firm-fixed-price delivery order is for the supply of Cevimeline Hydrochloride 30 mg capsules, a medication used to treat dry mouth. This specific award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $1,946.39 to AmerisourceBergen Drug Corp for Cevimeline HCL 30 mg capsules (100 count) on November 6, 2025, with completion scheduled for November 7, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, running through December 2026. The pharmaceutical...
- This contract award, valued at $3,254.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEVIMELINE HCL 30 MG CAPSULE 100S, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of December 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.00 firm fixed-price delivery order is for the supply of 4566374155 - CEVIMELINE HCL 30 MG CAPSULE 100S, a medication used to treat certain symptoms of Sjögren's syndrome. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,967.97 to AmerisourceBergen Drug Corp for Cevimeline HCL 30 mg capsules (100-count units) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cevimeline is a cholinergic medication used to treat dry mouth associated with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of a pharmaceutical capsule product, with a ceiling value of $3,386.08 and an ultimate completion date of July 14, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,264.84, is for the delivery of 36,000 unit capsules of a pharmaceutical product over a period ending on July 14, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,145.44 firm fixed-price delivery order contract is for the supply of 4568112339 - CHEMET 100 MG CAPSULE 100S, a medication. The contract is not set aside and has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,482.78, is for the delivery of 36,000 units of a 100-count capsule product. The contract type is a Firm Fixed Price Delivery Order, with a completion date of March 12, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRKN3Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,558.84 firm fixed-price delivery order is for 4,560,816,582 capsules of the drug Cevimeline HCL 30 mg, to be delivered by May 4, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that broader IDC. There was no set-aside designation for this particular award.
Generated 5/9/25, 10:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 5/3/23 |